BIOCRYST PHARMACEUTICALS, INC. (BCRX) Shareholders’ equity 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$119.2MFY2025 · since FY2016: $1.6M → -$119.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$119.2M | +75.0% |
| FY2024 | -$475.9M | -4.5% |
| FY2023 | -$455.5M | -54.6% |
| FY2022 | -$294.6M | -175.4% |
| FY2021 | -$107.0M | -455.4% |
| FY2020 | -$19.3M | -150.4% |
| FY2019 | $38.3M | -22.3% |
| FY2018 | $49.2M | -41.2% |
| FY2017 | $83.8M | +5208.4% |
| FY2016 | $1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice